BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37231184)

  • 1. Holobiont perspectives on tripartite interactions among microbiota, mosquitoes, and pathogens.
    Zheng R; Wang Q; Wu R; Paradkar PN; Hoffmann AA; Wang GH
    ISME J; 2023 Aug; 17(8):1143-1152. PubMed ID: 37231184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting Intimate Relationships: Controlling Mosquito-Transmitted Disease with Wolbachia.
    Caragata EP; Dutra HLC; Moreira LA
    Trends Parasitol; 2016 Mar; 32(3):207-218. PubMed ID: 26776329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mosquito holobiont: fresh insight into mosquito-microbiota interactions.
    Guégan M; Zouache K; Démichel C; Minard G; Tran Van V; Potier P; Mavingui P; Valiente Moro C
    Microbiome; 2018 Mar; 6(1):49. PubMed ID: 29554951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosquito Trilogy: Microbiota, Immunity and Pathogens, and Their Implications for the Control of Disease Transmission.
    Gabrieli P; Caccia S; Varotto-Boccazzi I; Arnoldi I; Barbieri G; Comandatore F; Epis S
    Front Microbiol; 2021; 12():630438. PubMed ID: 33889137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosquito Microbiota and Implications for Disease Control.
    Gao H; Cui C; Wang L; Jacobs-Lorena M; Wang S
    Trends Parasitol; 2020 Feb; 36(2):98-111. PubMed ID: 31866183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bacterium Wolbachia exploits host innate immunity to establish a symbiotic relationship with the dengue vector mosquito Aedes aegypti.
    Pan X; Pike A; Joshi D; Bian G; McFadden MJ; Lu P; Liang X; Zhang F; Raikhel AS; Xi Z
    ISME J; 2018 Jan; 12(1):277-288. PubMed ID: 29099491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mosquito microbiota and its influence on disease vectorial transmission].
    Heu K; Gendrin M
    Biol Aujourdhui; 2018; 212(3-4):119-136. PubMed ID: 30973141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosquito/microbiota interactions: from complex relationships to biotechnological perspectives.
    Ricci I; Damiani C; Capone A; DeFreece C; Rossi P; Favia G
    Curr Opin Microbiol; 2012 Jun; 15(3):278-84. PubMed ID: 22465193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Wolbachia be used to control malaria?
    Walker T; Moreira LA
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():212-7. PubMed ID: 21881776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wolbachia and the biological control of mosquito-borne disease.
    Iturbe-Ormaetxe I; Walker T; O' Neill SL
    EMBO Rep; 2011 Jun; 12(6):508-18. PubMed ID: 21546911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using bacteria to treat diseases.
    Caragata EP; Walker T
    Expert Opin Biol Ther; 2012 Jun; 12(6):701-12. PubMed ID: 22500583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromobacterium Csp_P reduces malaria and dengue infection in vector mosquitoes and has entomopathogenic and in vitro anti-pathogen activities.
    Ramirez JL; Short SM; Bahia AC; Saraiva RG; Dong Y; Kang S; Tripathi A; Mlambo G; Dimopoulos G
    PLoS Pathog; 2014 Oct; 10(10):e1004398. PubMed ID: 25340821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the microbiome on mosquito-borne diseases.
    Shi H; Yu X; Cheng G
    Protein Cell; 2023 Oct; 14(10):743-761. PubMed ID: 37186167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Microbiota Vaccine Reduces Avian Malaria Infection Within Mosquito Vectors.
    Aželytė J; Wu-Chuang A; Žiegytė R; Platonova E; Mateos-Hernandez L; Maye J; Obregon D; Palinauskas V; Cabezas-Cruz A
    Front Immunol; 2022; 13():841835. PubMed ID: 35309317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combating mosquito-borne diseases using genetic control technologies.
    Wang GH; Gamez S; Raban RR; Marshall JM; Alphey L; Li M; Rasgon JL; Akbari OS
    Nat Commun; 2021 Jul; 12(1):4388. PubMed ID: 34282149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence.
    Ramirez JL; Souza-Neto J; Torres Cosme R; Rovira J; Ortiz A; Pascale JM; Dimopoulos G
    PLoS Negl Trop Dis; 2012; 6(3):e1561. PubMed ID: 22413032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse Host and Restriction Factors Regulate Mosquito-Pathogen Interactions.
    Simões ML; Caragata EP; Dimopoulos G
    Trends Parasitol; 2018 Jul; 34(7):603-616. PubMed ID: 29793806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of the mosquito midgut microbiota in the defense against malaria parasites.
    Dong Y; Manfredini F; Dimopoulos G
    PLoS Pathog; 2009 May; 5(5):e1000423. PubMed ID: 19424427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosquito gut antiparasitic and antiviral immunity.
    Saraiva RG; Kang S; Simões ML; Angleró-Rodríguez YI; Dimopoulos G
    Dev Comp Immunol; 2016 Nov; 64():53-64. PubMed ID: 26827888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do avian malaria parasites reduce vector longevity?
    Martínez-de la Puente J; Gutiérrez-López R; Figuerola J
    Curr Opin Insect Sci; 2018 Aug; 28():113-117. PubMed ID: 30551761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.